HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of Astaxanthin for the Treatment of Atopic Dermatitis in a Murine Model.

Abstract
Atopic dermatitis (AD) is a common chronic inflammatory skin disease associated with various factors, including immunological abnormalities and exposure to allergens. Astaxanthin (AST) is a xanthophyll carotenoid that has recently been demonstrated to have anti-inflammatory effects and to regulate the expression of inflammatory cytokines. Thus, we investigated whether AST could improve the dermatitis and pruritus in a murine model of AD using NC/Nga mice. In addition to a behavioral evaluation, the effects of AST on the AD were determined by the clinical skin severity score, serum IgE level, histological analyses of skin, and by reverse transcription-PCR and Western blotting analyses for the expression of inflammation-related factors. AST (100 mg/kg) or vehicle (olive oil) was orally administered once day and three times a week for 26 days. When compared with vehicle-treated group, the administration of AST significantly reduced the clinical skin severity score. In addition, the spontaneous scratching in AD model mice was reduced by AST administration. Moreover, the serum IgE level was markedly decreased by the oral administration of AST compared to that in vehicle-treated mice. The number of eosinophils, total and degranulated mast cells all significantly decreased in the skin of AST-treated mice compared with vehicle-treated mice. The mRNA and protein levels of eotaxin, MIF, IL-4, IL-5 and L-histidine decarboxylase were significantly decreased in the skin of AST-treated mice compared with vehicle-treated mice. These results suggest that AST improves the dermatitis and pruritus in AD via the regulation of the inflammatory effects and the expression of inflammatory cytokines.
AuthorsYoko Yoshihisa, Tsugunobu Andoh, Kenji Matsunaga, Mati Ur Rehman, Takashi Maoka, Tadamichi Shimizu
JournalPloS one (PLoS One) Vol. 11 Issue 3 Pg. e0152288 ( 2016) ISSN: 1932-6203 [Electronic] United States
PMID27023003 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Cytokines
  • Xanthophylls
  • Immunoglobulin E
  • astaxanthine
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Cytokines (metabolism)
  • Dermatitis, Atopic (blood, drug therapy, immunology)
  • Drug Evaluation, Preclinical
  • Immunoglobulin E (blood)
  • Male
  • Mice
  • Skin (drug effects, metabolism, pathology)
  • Treatment Outcome
  • Xanthophylls (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: